VOL. XCIV, NO. 247
* WIDE MOAT STOCKS COMPARISON *
NO ADVICE
Monday, December 29, 2025
Stock Comparison
GSK plc vs Koninklijke Philips N.V.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
GSK plc
GSK · London Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Koninklijke Philips N.V.
PHIA · Euronext Amsterdam
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Koninklijke Philips N.V.'s moat claims, evidence, and risks.
View PHIA analysisComparison highlights
- Moat score gap: Koninklijke Philips N.V. leads (68 / 100 vs 62 / 100 for GSK plc).
- Segment focus: GSK plc has 3 segments (37.6% in Specialty Medicines); Koninklijke Philips N.V. has 3 segments (48.9% in Diagnosis & Treatment).
- Primary market structure: Oligopoly vs Oligopoly. Pricing power: Strong vs Moderate.
- Moat breadth: GSK plc has 4 moat types across 3 domains; Koninklijke Philips N.V. has 6 across 3.
Primary market context
GSK plc
Specialty Medicines
Branded specialty pharmaceuticals (HIV, oncology, immunology/respiratory)
Global
Hospitals, specialist physicians, payers
Innovator & branded manufacturer
37.6%
Koninklijke Philips N.V.
Diagnosis & Treatment
Medical imaging, image-guided therapy systems, and enterprise imaging informatics
Global
Hospitals & clinics
OEM systems + software + services
48.9%
Side-by-side metrics
Moat coverage
Shared moat types
No overlap yet.
GSK plc strengths
Koninklijke Philips N.V. strengths
Segment mix
GSK plc segments
Full profile >Vaccines
Oligopoly
Specialty Medicines
Oligopoly
General Medicines
Competitive
Koninklijke Philips N.V. segments
Full profile >Diagnosis & Treatment
Oligopoly
Connected Care
Oligopoly
Personal Health
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.